Adriaanse R, Brabant G, Endert E, Bemelman F J, Wiersinga W M
Department of Endocrinology, Academic Medical Center, University of Amsterdam, The Netherlands.
Eur J Endocrinol. 1994 Feb;130(2):113-20. doi: 10.1530/eje.0.1300113.
The circadian and pulsatile thyrotropin (TSH) and prolactin (PRL) release was investigated in a patient with slight hyperthyroidism due to a mixed TSH- and PRL-secreting pituitary adenoma. Blood was withdrawn every 10 min for 24 h (before and after medical treatment); pulse characteristics were analyzed by Desade and Cluster programs (values as mean +/- SD). The inappropriately high mean 24-h TSH concentration of 3.55 +/- 0.31 mU/l was associated with a higher mean 24-h TSH pulse amplitude but unaltered mean 24-h TSH pulse frequency relative to healthy controls. The nocturnal TSH surge (absolute surge 0.5 mU/l, relative surge 16%) was low, related to a loss of the usual nocturnal increase of TSH pulse amplitude and TSH pulse frequency. Chronic treatment with octreotide resulted in a modest clinical and biochemical improvement of the hyperthyroid state; addition of bromocriptine at a later stage had no further beneficial effect. At the end of the follow-up period the mean 24-h TSH paradoxically had increased to 5.33 +/- 0.81 mU/l. The nocturnal TSH surge also increased (absolute surge 1.9 mU/l, relative surge 42%), but circadian changes in TSH pulsatility remained absent. In the untreated period the increased mean 24-h PRL concentration of 234 +/- 24 micrograms/l was associated with an increased mean 24-h PRL amplitude, whereas the 24-h PRL pulse frequency (N = 4) was lower relative to controls. No circadian PRL rhythm was present. After octreotide and bromocriptine treatment the mean 24-h PRL concentration and mean 24-h PRL pulse amplitude were unchanged, but a clear nocturnal increase of PRL now was observed.(ABSTRACT TRUNCATED AT 250 WORDS)
对一名因促甲状腺激素(TSH)和催乳素(PRL)分泌混合型垂体腺瘤导致轻度甲状腺功能亢进的患者,研究了其昼夜节律性及脉冲式TSH和PRL释放情况。每10分钟采血一次,共24小时(药物治疗前后);通过Desade和Cluster程序分析脉冲特征(数值以平均值±标准差表示)。与健康对照组相比,该患者24小时TSH平均浓度不适当地高达3.55±0.31 mU/l,伴有更高的24小时TSH脉冲幅度,但24小时TSH脉冲频率未改变。夜间TSH高峰(绝对高峰0.5 mU/l,相对高峰16%)较低,这与TSH脉冲幅度和TSH脉冲频率通常的夜间增加缺失有关。奥曲肽长期治疗使甲状腺功能亢进状态在临床和生化方面有适度改善;后期加用溴隐亭未产生进一步有益效果。随访期末,24小时TSH平均值反常地增至5.33±0.81 mU/l。夜间TSH高峰也增加了(绝对高峰1.9 mU/l,相对高峰42%),但TSH脉冲的昼夜节律变化仍然不存在。在未治疗期间,24小时PRL平均浓度升高至234±24微克/升,伴有24小时PRL平均幅度增加,而24小时PRL脉冲频率(N = 4)相对于对照组较低。不存在PRL昼夜节律。奥曲肽和溴隐亭治疗后,24小时PRL平均浓度和24小时PRL平均脉冲幅度未改变,但现在观察到PRL有明显的夜间增加。(摘要截选至250词)